Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PMGC Holdings Inc. | CEO & CFO, Director, 10%+ Owner | Series B Preferred Stock | 3.04M | Mar 26, 2025 | By GB Capital Ltd | ||
PMGC Holdings Inc. | CEO & CFO, Director, 10%+ Owner | Common Stock | 983K | Nov 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELAB | PMGC Holdings Inc. | Mar 26, 2025 | 1 | $0 | 4 | Mar 28, 2025 | CEO & CFO, Director, 10%+ Owner |
QLGN | Qualigen Therapeutics, Inc. | Nov 7, 2024 | 0 | $0 | 3 | Nov 15, 2024 | Director |
ELAB | PMGC Holdings Inc. | Nov 13, 2023 | 0 | $0 | 3/A | Mar 28, 2025 | CFO, Director |